Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Solriamfetol reduces sleepiness in patients with OSA, narcolepsy
A recent study has shown the efficacy of solriamfetol as an alternative treatment for managing excessive daytime sleepiness (EDS) in patients with narcolepsy and obstructive sleep apnoea (OSA).
Solriamfetol reduces sleepiness in patients with OSA, narcolepsy
24 Jan 2023
Some antihypertensive medications may lower dementia risk
Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), angiotensin receptor blockers (ARBs), and dihydropyridine calcium channel blockers (CCBs) helps reduce the risk of dementia over a decade, but this beneficial effect decreases over time, according to a study.
Some antihypertensive medications may lower dementia risk
24 Jan 2023
Objective response to systemic therapy linked to overall survival in unresectable HCC
Objective response to first-line systemic therapy with lenvatinib or sorafenib independently predicts overall survival (OS) in individuals with unresectable hepatocellular carcinoma (HCC), as shown by the subanalysis of the REFLECT study.
Objective response to systemic therapy linked to overall survival in unresectable HCC
23 Jan 2023
ADHD medication use carries no excess cardiovascular disease risk
Attention-deficit/hyperactivity disorder (ADHD) medications do not appear to put users at increased risk of cardiovascular disease (CVD), although a modest risk increase for cardiac arrest or tachyarrhythmias cannot be ruled out, according to the results of a meta-analysis.
ADHD medication use carries no excess cardiovascular disease risk
22 Jan 2023
IV antihypertensives up myocardial injury risk in hospitalized patients with severe hypertension
Use of intravenous (IV) antihypertensive treatment appears to increase the risk of myocardial injury in patients who develop severe hypertension during hospitalization and without acute target end organ damage, reveals a recent study.
